Lataa...
Tumor molecular profiling of NSCLC patients using next generation sequencing
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and a tumor with a broad spectrum of targeted therapies already available or in clinical trials. Thus, molecular characterization of the tumor using next generation sequencing (NGS) technology, has become a key tool for facili...
Tallennettuna:
| Julkaisussa: | Oncol Rep |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783588/ https://ncbi.nlm.nih.gov/pubmed/29130105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.6051 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|